Last reviewed · How we verify
NCT05727332: VASST
Vascular Adaptations to Single-Sprint Training
NA trial testing Single-Sprint Training in Cardiovascular System in 46 participants. Completed in 5 December 2024.
31 July 2024
Quick facts
| Lead sponsor | University of Mississippi, Oxford |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 46 |
| Start date | 5 June 2023 |
| Primary completion | 31 July 2024 |
| Estimated completion | 5 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Single-Sprint Training
Conditions studied
- Cardiovascular System — all drugs for Cardiovascular System →
Sponsor
University of Mississippi, Oxford
Who can join
Adults 18 to 35, any sex, with Cardiovascular System. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The long-term objective of this research line is to identify and implement an effective and feasible intervention capable of preventing and/or reducing the burden of cardiometabolic and obesity-related diseases that affect Mississippians and others. The pursuit of this long-term objective will begin with achieving the specific aims proposed in this pilot project, which are to determine the effect of single sprint training for improving (1) systemic macro-vascular function, (2) local and systemic micro-vascular function, and (3) cardiorespiratory fitness. These aims will be achieved using a randomized controlled trial whereby 40 males and females will be randomized into an intervention group (n=20) or time-matched negative control group (n=20). The intervention group will perform a single maximal effort sprint on a cycle ergometer for twenty seconds 3 days/week for 4 weeks and the control group will be asked to maintain pre-intervention habits/behavior over 4 weeks. All outcome measures are non-invasive, and will be assessed pre-, mid-, and post-intervention, with the exception of cardiorespiratory fitness, which will be measured pre- and post-. To achieve aim 1, brachial artery flow-mediated dilation via ultrasonography and systolic and diastolic blood pressure via automated oscillometry will be measured on the arm. To achieve aim 2, post-occlusive reactive hyperemia via near-infrared spectroscopy and reactive hyperemia via ultrasound will be measured in the arm and leg, respectively. To achieve aim 3, pulmonary gas exchange will be measured during a graded exercise test on a cycle ergometer. All outcomes will be compared across time between conditions and sex with a three-way Bayesian Repeated Measures ANOVA using pre-values as covariates and an uninformed prior. 95% credible intervals will also be calculated to power future investigations using this intervention. If the intervention is found effective, future studies will be conducted to determine the efficacy of the intervention in larger groups and more clinical populations, and to determine the mechanisms mediating the adaptations. If ineffective, the knowledge gained will be used to develop future interventions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05727332
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular System
Currently open trials in the same condition.
- NCT07501923 — The Effects of Daytime, Nighttime, and Combined Heat Exposure on Human Health · NA · recruiting
- NCT06652425 — Acute Effects of Cold Exposure on Cardiovascular System · NA · recruiting
- NCT05575752 — Acute Health Effects of High Temperature Exposure · NA · active not recruiting
- NCT04153539 — Acute Health Effects of Traffic-Related Air Pollution Exposure · NA · active not recruiting
Other University of Mississippi, Oxford trials
Trials by the same sponsor.
- NCT06695988 — Time-restricted Eating Acceptability, Efficacy and Safety in Obesity · NA · recruiting
- NCT05908201 — Effects of Early Time Restricted Eating on Muscle Performance in Resistance Trained Individuals · NA · unknown
- NCT04280289 — CBD Cannabis Extract: Pharmacokinetic Studies · EARLY_PHASE1 · completed
- NCT04570917 — Online Education Intervention to Reduce Ageism Among Undergraduate Students · NA · completed
- NCT04073953 — Primaquine Enantiomers in G6PD Deficient Human Volunteers · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05727332 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Mississippi, Oxford
- Last refreshed: 26 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05727332.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing